Home Medical Devices Global Hemoglobin Testing Market Size, Demand, Report to 2032

Hemoglobin Testing Market

Hemoglobin Testing Market Size, Share & Trends Analysis Report By Product Type (Instruments, Reagents & Consumables), By Technology (Immunoassay, Chromatography, Spectrophotometer, Others), By End User (Hospitals & Clinics, Laboratories, Home Care Settings, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRMD56354DR
Study Period 2020-2032 CAGR 6.38%
Historical Period 2020-2022 Forecast Period 2024-2032
Base Year 2023 Base Year Market Size USD 2,738.00 Million
Forecast Year 2032 Forecast Year Market Size USD 4,880.00 Million
Largest Market North America Fastest Growing Market Asia Pacific
The sample report only takes 30 secs to download, no need to wait longer.

Market Overview

The global hemoglobin testing market size was valued at USD 2,738.00 million in 2023. It is estimated to reach USD 4,880.00 million by 2032, growing at a CAGR of 6.38% during the forecast period (2024–2032). 

Hemoglobin testing solutions includes instruments along with reagents and consumables used to measure the concentration of hemoglobin in the blood. Hemoglobin is a protein in red blood cells responsible for transporting oxygen from the lungs to the rest of the body and returning carbon dioxide from the tissues back to the lungs. The hemoglobin test is important for diagnosing and monitoring conditions such as anemia, polycythemia, thalassemia, and other blood disorders. This mainly involves technologies like chromatography, spectrophotometer and immunoassays for measuring the concentration of hemoglobin in the blood. The factors like technological advancements in hemoglobin testing devices, increase prevalence of hemoglobinopathies, and rising adoption of POCT devices are the major drivers contributing to the growth of the hemoglobin testing market. The development of portable and non-invasive hemoglobin meters, have made testing more accessible and efficient, further boosting the hemoglobin testing market revenue. Further, increasing health awareness and the emphasis on preventive healthcare encourage regular health check-ups, including hemoglobin testing, which drives the demand for advanced hemoglobin testing solutions. Moreover, the integration of digital health solutions and telemedicine facilitates remote monitoring and management of chronic conditions, enhancing the adoption of hemoglobin testing devices and propelling the hemoglobin testing market expansion. 

Market Dynamics

Global Hemoglobin Testing Market Drivers

Rising Prevalence of Anemia and Hemoglobin Disorders

The major factor driving the growth of hemoglobin testing market is rising number of anemia and hemoglobin disorders across the world. As these disorders continue to rise, the demand for accurate and reliable testing solutions is anticipated to rise, thereby propelling the hemoglobin testing market expansion. Anemia, is a condition characterized by low levels of healthy red blood cells, which requires early detection for proper treatment management. For instance, as per article by World Health Organization (WHO) in May 2023, stated that, anaemia is global health problem affecting 571 million women and 269 million young children worldwide. Thus, such rising number of anaemia cases across the world, result in demand for reliable hemoglobin testing solutions.

In addition, rising hemoglobin disorders such as sickle cell disease and thalassemia has amplified the importance of hemoglobin testing. For instance, as per the Thalassemia report by BGI Gen omics in November 2023, reported that, 300,000 to 400,000 children are born with severe hemoglobinopathies annually. These disorders require lifelong monitoring and management due to their complications. Thus, accurate hemoglobin testing plays a significant role in the diagnosis, treatment planning, and ongoing care for patients affected by these disorders. Recognizing the importance of hemoglobin testing in accurate diagnosis of hemoglobin conditions and to avoid further complications, various awareness campaigns are organised, resulting in demand for hemoglobin testing solutions. Thus, rising hemoglobin disorders along with increasing testing solutions are the factors anticipated to fuel the growth of hemoglobin testing market.

Technological Advancements in Hemoglobin Testing Devices

The rising advancements in hemoglobin testing device acts as a major driver in the hemoglobin testing market growth. The development of innovative techniques and instruments such as point of care testing (POCT) device has allowed more accurate, efficient, and comprehensive testing solutions. POCT devices are portable and user-friendly, which can be used anywhere, thereby, eliminating the need for complex laboratory procedures and reducing the time to diagnose. In addition, POCT devices are beneficial in resource-limited settings, where access to well-equipped laboratories is limited, allowing for timely screening and monitoring of anemia and other hemoglobin conditions.

Further, development and commercialization of advanced non-invasive hemoglobin testing solutions acts as a driver for the hemoglobin testing market. Many key players have developed devices which use optical sensors and spectroscopy techniques for hemoglobin detection. These devices rely on the light absorption properties of hemoglobin to estimate its concentration in the body without drawing blood. The devices offer advantages such as patient compliance & comfort, portability, cost-effective along with improved accessibility in resource-limited settings. For example, MGC Diagnostics Corporation, U.S. based company offers OrSense NBM 200, which is non-invasive device for analysis of the hemoglobin. The device improves patient comfort, minimizes infection rates and offers MGC Diagnostics software for test results. Thus, such advancements like portable and patient friendly devices increase the testing rates and drive the market growth.

Global Hemoglobin Testing Market Restraint

High Cost of Advanced Hemoglobin Testing Devices

The high cost of advanced hemoglobin testing devices along with the expenses for maintenance, calibration, and consumables like reagents and test strips possess significant barriers to the growth of hemoglobin testing market. The cost of advanced high-performance liquid chromatography (HPLC) systems and automated hematology analysers can be challenging for smaller healthcare facilities, clinics in rural or underserved areas, and healthcare systems in developing countries with limited budgets. This high initial investment can act as a barrier to adoption of advanced testing solutions and impact the hemoglobin testing market revenue.

Global Hemoglobin Testing Market Opportunities

Government and NGO Initiatives

The rising government initiatives to combat anemia and improve maternal & child health across the globe presents significant opportunities to the key players of the hemoglobin testing market. Many governments are launching programs and strategies for reducing the prevalence of anemia through regular screening and supplementation, thereby driving the need for reliable hemoglobin testing solutions. For example, the Ministry of Health and Family Welfare of India has launched Anemia Mukt Bharat strategy to combat hemoglobin disorders. In this initiative, testing using digital invasive hemoglobinometer along with increasing awareness for screening of anemia, has significantly increased the demand for hemoglobin testing solution and thereby drives the growth of the market.  In addition, various NGOs are also playing a crucial role in combating anemia and promoting maternal and child health. Organizations such as the United Nations Children's Fund (UNICEF) and the Global Alliance for Improved Nutrition (GAIN) have implemented programs for regular hemoglobin testing, supplementation, and education on nutritional practices which fuel the growth of the market. Thus, such initiatives are expected to offer lucrative opportunities to the key players of the hemoglobin testing market.

Emerging Markets and Expanding Healthcare Access

The rising healthcare expenditure along with improved access to healthcare services in developing regions like Asia-Pacific, Middle East & Africa and Latin America offer significant opportunities for market expansion. The growing burden of anemia & hemoglobin disorders, rapid economic development and improvements in healthcare infrastructure led to better access to diagnostic services including hemoglobin testing which fuels the growth of the market. In addition, growing focus on preventive healthcare and early detection of diseases, results in increased demand for routine blood tests, including hemoglobin testing which further fuels the market growth. Moreover, government emphasis on regular hemoglobin testing help in identification of potential health issues at an early stage, enabling timely intervention and treatment. Thus, expanding healthcare along with other factors in emerging markets fuel the growth and present crucial opportunity to the key players of the hemoglobin testing market.

Regional Analysis

Based on region, the global hemoglobin testing market is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

North America Dominates the Global Market

North America is the most significant global hemoglobin testing market shareholder and is expected to expand substantially during the forecast period. North America stands as a prominent region in the global hemoglobin testing market, characterized by robust technological advancements, increasing hemoglobin disorders, and established major players of the market.

The United States hemoglobin testing market is leading in terms of market share. The advanced healthcare system, characterized by high healthcare expenditure and extensive insurance coverage that ensures access to diagnostic technologies drives the U.S. hemoglobin testing market share. In addition, emphasis on early detection and preventive care, supported by numerous public health initiatives and awareness campaigns for hemoglobin disorders further fuels the growth of the market. Moreover, presence of established leading medical device manufacturers and ongoing technological advancements, such as the development of non-invasive testing methods and portable devices, further propel the U.S. hemoglobin testing market growth.

The Canadian hemoglobin testing market is poised to grow due to country's universal healthcare system, which ensures comprehensive coverage for diagnostic tests and promotes equitable access to healthcare services. In addition, increasing number of people suffering from anemia and chronic diseases necessitates frequent hemoglobin monitoring, thereby propelling the demand for reliable hemoglobin testing solutions. Moreover, various government initiatives aimed at improving maternal and child health, which include routine hemoglobin screening, is anticipated to drive the growth of hemoglobin testing market revenue.

These factors are estimated to drive the Asia-Pacific hemoglobin testing market growth.

Asia-Pacific region is a pivotal market for the hemoglobin testing industry. The major factors driving the growth of hemoglobin testing market in Asia Pacific are economic development in many countries leading to the improved healthcare infrastructure and increased healthcare spending. In addition, countries of Asia Pacific are investing in public health initiatives to combat prevalent conditions such as anemia and other hemoglobin disorders which fuels the growth of the hemoglobin testing market. Further, higher burden of hemoglobin disorders and growing health awareness are contributing to a higher demand for regular health check-ups and diagnostics, including hemoglobin testing solutions. Moreover, efforts for improving maternal and child health through national health programs are also driving the adoption of hemoglobin testing, especially in developing countries. Thus, all above factors contribute to the growth of Asia Pacific hemoglobin testing market during the forecast period.

China's hemoglobin testing market has a major role in shaping the dynamics of the Asia-Pacific hemoglobin testing market. The increasing investments in healthcare infrastructure, modernizing hospitals and medical centres with advanced technology and equipment necessary for hemoglobin testing is anticipated to drive the market growth. Additionally, increase in adoption of digital health solutions are further facilitating the widespread use of hemoglobin testing devices in both urban and rural settings. Moreover, the Chinese government has been actively promoting healthcare reforms to increase access to high-quality medical care, leading to a rise in the adoption of portable medical devices like hemoglobin testing devices.

Indian Hemoglobin Testing Market drivers include high prevalence of anemia and hemoglobinopathies, national health programs and rapid expansion of healthcare infrastructure. For instance, as per the article published by Indian Journal of Community Medicine in December 2023, stated that, prevalence of anemia is 25% in men and 31% in adolescent boys, in India. Moreover, rapid healthcare infrastructure expansion especially in rural areas through initiatives like Ayushman Bharat, is enhancing access to diagnostic services.

Thus, the factors above are estimated to boost the Asia-Pacific hemoglobin testing market growth.

Report Scope

Report Metric Details
Segmentations
By Product Type
  1. Instruments
  2. Reagents & Consumables
By Technology
  1. Immunoassay
  2. Chromatography
  3. Spectrophotometer
  4. Others
By End User
  1. Hospitals & Clinics
  2. Laboratories
  3. Home Care Settings
  4. Others
Company Profiles Bio-Rad Laboratories, Inc. ACON Laboratories, Inc. F. Hoffmann-La Roche Ltd Abbott Laboratories Beckman Coulter, Inc. (Danaher Corporation) Thermo Fisher Scientific Daiichi Biotech Services Sdn Bhd MGC Diagnostics Corporation DiaSys Diagnostic Systems Sysmex Corporation Erba Mannheim EKF Diagnostics Holdings ARKRAY, Inc. Sanguina Inc.
Geographies Covered
North America U.S. Canada
Europe U.K. Germany France Spain Italy Russia Nordic Benelux Rest of Europe
APAC China Korea Japan India Australia Singapore Taiwan South East Asia Rest of Asia-Pacific
Middle East and Africa UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of MEA
LATAM Brazil Mexico Argentina Chile Colombia Rest of LATAM
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Segmental Analysis

The global hemoglobin testing market is segmented by product type, technology, and end user.

Based on product type, the global market is divided into instruments and reagents & consumables. 

The instrument segment dominates the global market. The instruments such as automated haematology analyser, POCT devices are available for accurate and rapid hemoglobin measurement, crucial for diagnosing and managing conditions like anemia and other hemoglobinopathies. In addition, rising number of people suffering from chronic diseases that require regular hemoglobin monitoring, such as diabetes and chronic kidney disease, drives the demand for these instruments. Further, end users like hospitals, clinics and laboratories prefer using advanced instruments due to their ability to handle high sample volumes efficiently, reducing turnaround times and improving patient care. Moreover, the rising adoption of POCT instruments, which provide immediate results and can be used in diverse settings like home care, also contributes significantly to the dominance of the instrument segment.

Based on technology, the global hemoglobin testing market is divided into immunoassay, chromatography, spectrophotometer and others. 

The spectrophotometer segment dominates the global hemoglobin testing market owing to its superior accuracy, reliability, and versatility in measuring hemoglobin levels. These devices can handle a high number of samples, making them ideal for use in hospitals, clinics, and diagnostic laboratories where efficient and large-scale testing is required. Moreover, the spectrophotometers are capable of performing various types of hemoglobin tests, such as total hemoglobin concentration and hemoglobin variants, enhancing their utility in comprehensive diagnostic settings, thereby are the preferred choice in hospitals and laboratories. The continued technological advancements and integration of automated features in spectrophotometers further boost their adoption, offering ease of use, reduced human error, and improved workflow efficiency.

Based on end user, the global market is bifurcated into hospitals & clinics, laboratories, home care settings and others. 

The hospitals & clinics segment is estimated to account for the largest share in terms of revenue in 2023. The hospitals & clinics are primary centres for diagnostic testing, thus making them essential hubs for hemoglobin testing. The high patient influx requiring regular monitoring for conditions such as anemia, diabetes, and chronic kidney disease, result in demand for hemoglobin tests. In addition, the hospitals and clinics often have access to the latest testing technologies and comprehensive laboratory facilities, which enhance the reliability and speed of hemoglobin testing. Moreover, the integration of electronic health records (EHR) and other digital health tools in these institutions also facilitates better management and follow-up of patients, propelling the demand for continuous hemoglobin monitoring and driving the segment growth.

Market Size By Product Type

Market Size By Product Type
  • Instruments
  • Reagents & Consumables
  • Recent Developments

    Analyst’s Perspective

    As per our research analysts, the market for hemoglobin testing is set to experience strong expansion, owing to combination of factors such as technological progress, rise in blood disorders, and the growth of medical facilities worldwide. The innovations for development of portable and non-invasive hemoglobin testing devices have propelled the adoption of devices in rural settings. Further, emphasis on preventive healthcare along with focus on maternal and child health after birth suffering from blood disorders has increased the demand of advanced hemoglobin testing systems. The market in emerging regions like Asia-Pacific, especially in China and India, is also growing due to more investments in healthcare and an increase in awareness regrading hemoglobin disorders and importance of screening.

    Key Players

    Hemoglobin Testing Market Share of Key Players

    Hemoglobin Testing Market Share of Key Players
    Bio-Rad Laboratories, Inc. ACON Laboratories, Inc. F. Hoffmann-La Roche Ltd Abbott Laboratories Beckman Coulter, Inc. (Danaher Corporation) Thermo Fisher Scientific Daiichi Biotech Services Sdn Bhd MGC Diagnostics Corporation DiaSys Diagnostic Systems Sysmex Corporation Erba Mannheim EKF Diagnostics Holdings ARKRAY, Inc. Sanguina Inc. Others

    Frequently Asked Questions (FAQs)

    How big is the hemoglobin testing market?
    The global hemoglobin testing market size was valued at USD 2,738.00 million in 2023. It is estimated to reach USD 4,880.00 million by 2032, growing at a CAGR of 6.38% during the forecast period (2024–2032). 
    Rising prevalence of anemia and hemoglobin disorders, technological advancements in hemoglobin testing devices are some key drivers supporting the growth of the hemoglobin testing market.
    North America region has the highest growth rate in the hemoglobin testing market.
    The key players in the global hemoglobin testing market include Bio-Rad Laboratories, Inc., ACON Laboratories, Inc., F. Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific, Daiichi Biotech Services Sdn Bhd, MGC Diagnostics Corporation, DiaSys Diagnostic Systems, Sysmex Corporation, Erba Mannheim, EKF Diagnostics Holdings, ARKRAY, Inc., Sanguina Inc.
    Spectrophotometer technology segment is the leading segment for the market during forecast period.


    We are featured on :